Scientists Have No Business Trying To Sway Public Policy

All too often, epidemiologic science is held up to be incontrovertible fact, synonymous with immutable truth, and then, to make matters worse, it’s accepted blindly by the popular press and reported as such. Later, if the conclusions or editorial comments by researchers are found by peer review to be deceptive, conceptually flawed, or distorted, it is too late to correct original perceptions. First impressions are lasting impressions, regardless of whether they’re inaccurate, inva

Written byFrank Resnik
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

All too often, epidemiologic science is held up to be incontrovertible fact, synonymous with immutable truth, and then, to make matters worse, it’s accepted blindly by the popular press and reported as such. Later, if the conclusions or editorial comments by researchers are found by peer review to be deceptive, conceptually flawed, or distorted, it is too late to correct original perceptions. First impressions are lasting impressions, regardless of whether they’re inaccurate, invalid, or based on hyped scientific findings.

The entire debate on environmental tobacco smoke (ETS)—that is, diffused smoke in a room as a result of people smoking tobacco products—is a prime example of this folly.

Epidemiologists and medical scientists should be both baffled and alarmed by the attention given the flurry of .studies concerning ETS, one of the most recent cases being a study in New York state concerning detection of trace amounts of cotinine in the urine ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies